ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users

Advanced Bionics

Status: Completed

Conditions: Implant

Treatments: Device: ClearVoice

Study type: Interventional

Funder types: Industry

Identifiers

NCT01066780

CR0309

Details and patient eligibility

About

The purpose of this study is to collect information about how the new sound-processing affects the ability to hear in everyday listening situations.

Enrollment: 48 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Post-lingually deafened,
• experienced (6 months device use),
• adult users of the Harmony HiResolution Bionic Ear System and HiRes Fidelity 120 sound processing.
• English language proficiency

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

48 participants in 2 patient groups

Group A: ClearVoice Medium

Experimental group

Description:

Chronic use of ClearVoice MEDIUM for two weeks followed by chronic use of ClearVoice HIGH for two weeks.

Treatment:

Device: ClearVoice

Group B: ClearVoice High

Experimental group

Description:

Chronic use of ClearVoice HIGH for two weeks followed by chronic use of ClearVoice MEDIUM for two weeks.

Treatment:

Device: ClearVoice